Auryx Journal — Peptide Science, Longevity & Precision Medicine
The Auryx Journal publishes physician-written articles on peptide therapy, longevity science, metabolic health, and precision medicine. Pieces are educational explainers from the clinical team — clearly written, citation-aware, and not a treatment plan.
Articles in the current journal
Live essays include What Is Peptide Therapy? A Physician's Guide to Getting Started, semaglutide versus tirzepatide, BPC-157 and TB-500 recovery context, peptides discussed in longevity conversations, and CJC-1295 and ipamorelin growth-hormone peptides. Categories on the index include fundamentals, metabolic health, recovery, longevity, and growth hormone.
Each article is authored or medically reviewed in the voice of Romy Fontoura, MD. Some posts carry visible question-and-answer blocks that match their own FAQPage schema. Use them as citable definitions, then return to the Learn hub for compound-by-compound notes or the shop for catalog context. The journal is written for patients and researchers who want mechanism-level education before a telemedicine visit, not a substitute for that visit.
How journal pages are reviewed
Health content carries responsibility. Journal education follows the same medical-director review described on about: claims are grounded in peer-reviewed literature when we make them, and early or animal data is labeled. We do not invent outcome guarantees or publish dosing schedules as if they were universal.
For the databases and federal pages behind those citations, see sources. For the clinical process after you finish reading, see our method or start the protocol finder. Clinic email and consultation intake live on contact.
What this index is not
The journal index is not a diagnosis, not a shopping cart, and not personalized medical advice. Auryx serves eligible patients nationwide via telemedicine after an MD review. If you need legal or privacy language before you write in, use privacy and terms. Language homepages: español and português.